Presentation is loading. Please wait.

Presentation is loading. Please wait.

Donor-Recipient ABO Compatibility Independently Influences Survival after Allogeneic HSCT: Outcomes of 281 Patients from a Single Centre  Duncan Purtill,

Similar presentations


Presentation on theme: "Donor-Recipient ABO Compatibility Independently Influences Survival after Allogeneic HSCT: Outcomes of 281 Patients from a Single Centre  Duncan Purtill,"— Presentation transcript:

1 Donor-Recipient ABO Compatibility Independently Influences Survival after Allogeneic HSCT: Outcomes of 281 Patients from a Single Centre  Duncan Purtill, MBBS, FRACP, FRCPA, Marian Sturm, PhD, Anastasia Keegan, MBBS, FRACP, FRCPA, Megan Margaria, CN Bsc (Nursing), Susan Buffery, RN, Annette Le Viellez, Paul Chiappini, Julian P. Cooney, MBBS FRACP FRCPA, Paul Cannell, MBBS FRCPA FRACP, Matthew Wright, MBBS FRACP FRCPA  Biology of Blood and Marrow Transplantation  Volume 22, Issue 3, Pages S348-S349 (March 2016) DOI: /j.bbmt Copyright © Terms and Conditions

2 Figure Overall Survival According to Donor — Recipient ABO Compatibility Biology of Blood and Marrow Transplantation  , S348-S349DOI: ( /j.bbmt ) Copyright © Terms and Conditions


Download ppt "Donor-Recipient ABO Compatibility Independently Influences Survival after Allogeneic HSCT: Outcomes of 281 Patients from a Single Centre  Duncan Purtill,"

Similar presentations


Ads by Google